272 related articles for article (PubMed ID: 14870516)
21. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.
Mason BJ
Eur Neuropsychopharmacol; 2003 Dec; 13(6):469-75. PubMed ID: 14636963
[TBL] [Abstract][Full Text] [Related]
22. Does the alcoholic's remedy come in a pill?
Gordon SM
Behav Healthc Tomorrow; 2001 Aug; 10(4):SR29-30, SR34. PubMed ID: 11496583
[No Abstract] [Full Text] [Related]
23. Current pharmacotherapies of alcoholism: a U.S. perspective.
Anton RF; Swift RM
Am J Addict; 2003; 12(s1):s53-s68. PubMed ID: 14972780
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacological review of alcoholic dependence treatment].
Oural L; Paris MV; Sullivan O; Polach M; Pavlovsky F; Capece J
Vertex; 2008; 19(77):512-21. PubMed ID: 18443665
[TBL] [Abstract][Full Text] [Related]
25. New developments in the pharmacotherapy of alcohol dependence.
Myrick H; Brady KT; Malcolm R
Am J Addict; 2001; 10(s1):s3-s15. PubMed ID: 11268820
[TBL] [Abstract][Full Text] [Related]
26. Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence.
Colagiuri B; Morley K; Boakes R; Haber P
Psychother Psychosom; 2009; 78(3):167-71. PubMed ID: 19270472
[TBL] [Abstract][Full Text] [Related]
27. New therapies for alcohol dependence open options for office-based treatment.
Kuehn BM
JAMA; 2007 Dec; 298(21):2467-8. PubMed ID: 18056897
[No Abstract] [Full Text] [Related]
28. Pharmacotherapy for alcohol dependence.
West SL; Garbutt JC; Carey TS; Lux LJ; Jackman AM; Tolleson-Rinehart S; Lohr KN; Crews FT
Evid Rep Technol Assess (Summ); 1999 Jan; (3):1-5. PubMed ID: 11487800
[No Abstract] [Full Text] [Related]
29. Prevention of relapse in alcohol dependence.
Malerich JA
Am Fam Physician; 1999 Apr; 59(7):1753-4. PubMed ID: 10208698
[No Abstract] [Full Text] [Related]
30. Extended-release intramuscular naltrexone: a viewpoint by Henry R Kranzler.
Kranzler HR
Drugs; 2006; 66(13):1753-4. PubMed ID: 16978038
[No Abstract] [Full Text] [Related]
31. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
Bouza C; Angeles M; Muñoz A; Amate JM
Addiction; 2004 Jul; 99(7):811-28. PubMed ID: 15200577
[TBL] [Abstract][Full Text] [Related]
33. Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.
Soyka M; Rösner S
Curr Drug Abuse Rev; 2008 Nov; 1(3):280-91. PubMed ID: 19630726
[TBL] [Abstract][Full Text] [Related]
34. The state of pharmacotherapy for the treatment of alcohol dependence.
Garbutt JC
J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
[TBL] [Abstract][Full Text] [Related]
35. Acamprosate campral for alcoholism.
Med Lett Drugs Ther; 2005 Jan; 47(1199):1-3. PubMed ID: 15599336
[TBL] [Abstract][Full Text] [Related]
36. Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
Soyka M; Chick J
Am J Addict; 2003; 12(s1):s69-s80. PubMed ID: 14972781
[TBL] [Abstract][Full Text] [Related]
37. International update: new findings on promising medications.
Litten RZ
Alcohol Clin Exp Res; 1996 Nov; 20(8 Suppl):216A-218A. PubMed ID: 8947268
[No Abstract] [Full Text] [Related]
38. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
39. Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?
Doggrell SA
Expert Opin Pharmacother; 2006 Oct; 7(15):2169-73. PubMed ID: 17020440
[TBL] [Abstract][Full Text] [Related]
40. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
Rösner S; Leucht S; Lehert P; Soyka M
J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
